Bio-Rad Laboratories | BIO - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 10.57B 171M 2025-12
Agilent USD 1.5B 23M 2026-03
Becton, Dickinson and Co. USD 2.2B 303M 2026-03
Bio Techne USD 214.56M 29.95M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Bruker USD 542.7M 2.2M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Danaher USD 4.76B 845M 2026-03
General Electric Aerospace USD 22.18B 6.89B 2026-03
Illumina USD 738M 116M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Laboratory Of America USD 2.45B 189.8M 2026-03
Merck USD 11.78B 345M 2025-12
Mettler Toledo International USD 708.21M 70.04M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Quest Diagnostics USD 1.59B 179M 2026-03
Repligen USD 151.55M 7.03M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Siemens EUR 28.1B 1.3B 2026-03
Standard Biotools USD 13.43M 109K 2025-12
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Tosoh JPY 289.91B 4.28B 2026-03
Waters USD 1.76B 930.16M 2026-03